AI help for rheumatoid arthritis diagnosis
Part of Bones, joints & muscles, Brain & nervous system, Digestive system, Eyes & vision, Heart & circulation, Hormones & metabolism, Immune system & allergy, Lungs & breathing, Mouth & dental, Skin clinical trials.
This trial tests whether artificial intelligence (AI) can improve how doctors spot complications in people newly diagnosed with rheumatoid arthritis (RA), a condition that causes joint pain and swelling. The goal is to see if AI can make diagnosis faster and more accurate in real-world hospital settings.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have just been told you have rheumatoid arthritis (RA) for the first time.
- You are staying in the hospital for your RA care.
- You were admitted during the time the study is happening.
- You will not be in the study if it turns out you don't have RA.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a smartphone-based exercise program designed with artificial intelligence to help people with rheumatoid arthritis, especially those with knee pain. It aims to see if the program can improve mobility and reduce symptoms.
This study uses AI, brain scans, and blood tests to understand chronic pain in rheumatoid arthritis (RA). It may help find better ways to treat pain in the future.
This study tests a new, AI-powered treatment approach for rheumatoid arthritis. It's for people with active disease who haven't used certain biologic or targeted therapies in the last 6 months.
This study is looking at early rheumatoid arthritis (RA) and heart health. It compares people newly diagnosed with RA (within the last 6 months) to healthy people of similar age and sex. The goal is to see if there are early signs of hardening of the arteries in people with RA.
This study follows people who are at high risk for developing rheumatoid arthritis, as well as first-degree relatives of RA patients and people with very early untreated RA. It aims to learn more about the disease so doctors can better predict and prevent it.
This study tests whether an artificial intelligence system can help doctors figure out what rare disease you have when previous doctors couldn't find an answer. You'll work with the AI tool alongside your regular doctor to try to reach a diagnosis.
Hear when a new Osteoporosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.